Intravenous Sodium Fluorescein Versus Oral Phenazopyridine for Ureteral Patency
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02757417 |
|
Recruitment Status :
Withdrawn
(Study never started)
First Posted : May 2, 2016
Last Update Posted : May 6, 2022
|
Sponsor:
University Hospitals Cleveland Medical Center
Collaborators:
Megan Billow
Graham Chapman
Sangeeta Mahajan
Alex Soriano
Sherif El-Nashar
Information provided by (Responsible Party):
University Hospitals Cleveland Medical Center
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
| Recruitment Status : | Withdrawn |
|---|---|
| Estimated Primary Completion Date : | January 2018 |
| Estimated Study Completion Date : | December 2019 |